Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Friedman

Showing results (1421-1430 of 1,475) with videos related to

Pageof 148
Sort By:
Arquivos De Neuro-Psiquiatria|May 18, 2026
True vignettes: interesting, illustrative examples of behavioral abnormalities in people with Parkinson's diseaseJoseph H Friedman, Umer Akbar, Blake Beehler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial resultsD D Bigner, M T Brown, A H Friedman, et al.
Journal of Neurosurgery|December 22, 2009
Poor drug distribution as a possible explanation for the results of the PRECISE trialJohn H Sampson, Gary Archer, Christoph Pedain, et al.
The International Journal of Neuroscience|June 14, 2011
Clinical vignettes in Parkinson's disease: a collection of unusual medication-induced hallucinations, delusions, and compulsive behavioursJoseph H Friedman, P Agarwal, R Alcalay, et al.
Neuro-Oncology|April 12, 2008
Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumorsJohn H Sampson, Gamal Akabani, Gerald E Archer, et al.
Neuro-Oncology|May 12, 2004
Phase 2 trial of BCNU plus irinotecan in adults with malignant gliomaDavid A Reardon, Jennifer A Quinn, Jeremy N Rich, et al.
Nature|March 13, 2015
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patientsDuane A Mitchell, Kristen A Batich, Michael D Gunn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial resultsM T Brown, R E Coleman, A H Friedman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant gliomaH S Friedman, R E McLendon, T Kerby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant gliomaJennifer A Quinn, James Pluda, M Eileen Dolan, et al.
Pageof 148

Showing results (1421-1430 of 1,475) with videos related to

Sort By:
Pageof 148
Arquivos De Neuro-Psiquiatria|May 18, 2026
True vignettes: interesting, illustrative examples of behavioral abnormalities in people with Parkinson's diseaseJoseph H Friedman, Umer Akbar, Blake Beehler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial resultsD D Bigner, M T Brown, A H Friedman, et al.
Journal of Neurosurgery|December 22, 2009
Poor drug distribution as a possible explanation for the results of the PRECISE trialJohn H Sampson, Gary Archer, Christoph Pedain, et al.
The International Journal of Neuroscience|June 14, 2011
Clinical vignettes in Parkinson's disease: a collection of unusual medication-induced hallucinations, delusions, and compulsive behavioursJoseph H Friedman, P Agarwal, R Alcalay, et al.
Neuro-Oncology|April 12, 2008
Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumorsJohn H Sampson, Gamal Akabani, Gerald E Archer, et al.
Neuro-Oncology|May 12, 2004
Phase 2 trial of BCNU plus irinotecan in adults with malignant gliomaDavid A Reardon, Jennifer A Quinn, Jeremy N Rich, et al.
Nature|March 13, 2015
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patientsDuane A Mitchell, Kristen A Batich, Michael D Gunn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial resultsM T Brown, R E Coleman, A H Friedman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant gliomaH S Friedman, R E McLendon, T Kerby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant gliomaJennifer A Quinn, James Pluda, M Eileen Dolan, et al.
Pageof 148